Wednesday, Apr 23

New Study Finds Relationship Between Fibromylagia and Autonomic Dysfunction; Suggests New Treatment Options

A recent study published in the Journal of Clinical Rheumatology explores the connection between fibromyalgia and sympathetic nervous system dysfunction. This meta-study found that 65% of case-control studies found in the PubMed and EMBASE databases described “sympathetic nervous system predominance” as the “common clustering underlying pathogenesis”1, meaning that the onset

Treating Fibromyalgia Patients in a Whole New Way

Fibromyalgia is a difficult syndrome to diagnose and to treat. Worse yet for fibro patients, a large portion of the medical community still does not recognize fibromyalgia as a real or serious condition. What treatments do exist are inconsistent in their effectiveness and largely treat very specific symptoms like pain

Dr. Arata Presents Results of New Study at ISET

The results of Synergy’s new study were released today at the International Symposium on Endovascular Therapy (ISET). The study, which can be found here, investigates whether balloon angioplasty induces alterations in the hypothalamus pituitary adrenal (HPA) axis as indicated by changes in levels of ACTH and Cortisol. 88 patients in

A New Option for Chronic Lyme Patients

Acute Lyme is an accepted infectious disease. It has familiar symptoms of an infection such as fever, rash or malaise. This condition is accepted by mainstream medicine, and the treatment is fairly well defined. However, when Lyme disease develops into chronic Lyme, both the treatment regimen and even the nature

Studies Investigate Relationship Between New Treatment and Reduction in Dysautonomia Symptoms in MS Patients

Synergy Health has published a new study, the first in a series, investigating the relationship between treatment for CCSVI (and its successor treatment, TVAM therapy) and the improvement of the symptoms of dysautonomia among M.S. Patients and other groups suffering from autonomic dysfunction. Read our latest study here: While

A New Approach to Treating MS Patients

As MS patients are all too well aware, multiple sclerosis can cause a wide range of symptoms, from weakness and numbness to visual changes. But most MS patients don’t realize that they are very likely to have another condition known as autonomic dysfunction, or dysautonomia, and that it is dysautonomia

A Promising New Treatment for Dysautonomia Patients

Most patients diagnosed with isolated or “pure” dysautonomia – autonomic dysfunction with no underlying neurological condition – generally first seek medical treatment for cardiovascular issues, such as POTS (where the heart rate fluctuates based on body position) or syncope (the tendency to pass out frequently). As a result, dysautonomia is

The Current Status of CCSVI Treatment

Since the condition known as chronic cerebrospinal venous insufficiency (CCSVI) was first described by Dr. Paolo Zamboni in 2008, the relationship between this condition and MS has been investigated and rigorously debated. Yet while Zamboni’s original study saw an over 90% correlation between MS and CCSVI, later studies have cast